Humanity is at the verge of a serious crisis due to COVID-19 (coronavirus disease-2019) pandemic caused by a novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2). The disease was reported earlier from Wuhan, China in December 2019 and in a matter of weeks, witnessed a meteoric spread to almost every part of the world ([@bb0100]). New emerging epicentres like Italy, Iran, Spain and USA have amplified the crisis. The looming disaster of its spread to over populated countries with fragile health infrastructure necessitates even more urgently to implement population-centred approaches to understand this outbreak and fight the pandemic. Next generation sequencing (NGS) has helped the community to explore the evolutionary diversity and mutational propensity of the virus. Efforts of medical and scientific fraternity have been unprecedented with genetic data being available at exhilarating speed along with rapid epidemiological and clinical data sharing - all aiming to translate these into developing effective interventions ([@bb0010]).

We analysed the genome sequence of available clinical isolates (n=257) to comprehend the phylogenetic diversity of the isolates ([@bb0070]). Genome sequences of SARS-COV-2 were retrieved from GISAID (<https://www.gisaid.org>) as on 11th Mar 2020 followed by manual curation to remove redundancy (100% identical sequences) using mmseq2 software ([@bb0055]). Multiple sequence alignments (MSA) of all coronavirus whole genomes were performed using MUSCLE and MAFFT software ([@bb0045]; [@bb0060]). Phylogenetic plots were constructed using iTOL (<https://itol.embl.de>) ([@bb0040]) software based on the neighbour-joining method. Coding ORF's in SARS-CoV-2 genomes were predicted by Glimmer ([@bb0020]) and homology search was performed using mmseq2. Variable region analysis among SARS-CoV-2 ORF's was done using in-house protocols. Mutations were computed with Wuhan-Hu-1/2019 isolate as a reference strain using SeaView ([@bb0025]). MSA of the ORF's were performed by MAFFT and MUSCLE as above. R software was used to generate the plots ([@bb0015]). tSNE clustering was done using Rtsne employing R (<https://cran.r-project.org/>) package ([@bb0035]).

The mutations arising during human to human spread could provide insights into transmission dynamics and, compounded with clinical and epidemiological data can predict disease prognosis ([@bb0090]). Moreover, the mutational propensity of RNA viruses can impede the development of interventions which is an emerging challenge before the scientific community. Our analyses employing advanced machine learning approaches revealed a great deal of genetic diversity emerging among clinical isolates ([Fig. 1](#f0005){ref-type="fig"}A) along the time line. This genome clustering highlights evolution of SARS-CoV-2 into distinct clades that were driven through specific mutations in its ORF\'s as it spread around the globe from Dec 2019 to March 2020 ([Fig. 1](#f0005){ref-type="fig"}A). One fascinating aspect that emerged is the observed diversity of viral strains in every continent ([Fig. 1](#f0005){ref-type="fig"}B). However, there was no geographical clustering of the isolates and every continent seems to have multiple introductions of different viral strains. Earlier pandemics had geographical signatures in their sequences that abetted the tracing of new infections ([@bb0050]). Those markers are obscure yet in the current pandemic possibly due to rampant globalisation, a major bottleneck in tracing the lineages. The intriguing difference in the significantly more than average transmission and mortality in the Lombardy region of Italy, compared to other European countries or that of African continent or even China, could not be correlated to any specific molecular divergence pattern and very likely a reflection of the advanced age/co-morbidity. Interestingly, we observed 5' terminal of the genome to be more variable and prone to mutations, as compared to 3' terminal. It appears that ORF1ab, spike, ORF3a and E are key drivers of diversity among strains ([Fig. 1](#f0005){ref-type="fig"}C) with receptor binding domain (RBD) of spike emerging as mutational hotspot ([@bb0005]; [@bb0030]; [@bb0075]; [@bb0080]). Interaction of RBD with ACE2 (angiotensin-converting enzyme 2) could determine the outcome of infection indicating the clinical importance of these mutations ([@bb0065]; [@bb0085]; [@bb0095]). Our phylogenetic analyses reveal at least five different clades circulating as of date and more divergence is expected with time ([Fig. 1](#f0005){ref-type="fig"}D). We believe that these emerging mutations, once corroborated with viral pathogenesis and clinical characteristics along with epidemiological correlates would be valuable in predicting disease progression and also tracing pathogen mobility and re-emergence.Fig. 1**Visual depiction of emerging genomic diversity among clinical isolates of SARS-CoV-2** (A) SARS-CoV-2 separating into different clades since its identification in December 2019 till March 2020 using Wuhan-Hu-1/2019 (NC_045512) as reference strain (courtesy: [nextstrain.org](http://nextstrain.org){#ir0005}). Amino acid mutations in individual ORF's are also shown that lead to clade separation. (B) t-distributed stochastic neighbour embedding (tSNE), a non-linear dimensionality reduction Machine learning (ML) technique plot for COVID-19 strains (n=257, based on the global ORF similarity between genomes) highlights two dominant clusters; Europe and North America + Asia). Diffuse geographical clustering was observed for other strains across continents - an indication of the effects of human migration in the modern population. (C) Mutation analysis of all ORF's from analysed COVID-19 strains (n=257). Plots for individual amino acids in ORF's show that every type of amino acid has undergone mutations, predominantly in ORF's 1ab, S, 3a and E. (D) Diversity in clinical isolates indicate that SARS-CoV-2 has divulged into at least five different clades, evolutionary distinct from Bat CoV RaTG13 and Beta-CoV-pangolins.Fig. 1
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